| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flagellin | 20 | 2015 | 38 | 4.220 |
Why?
|
| Adjuvants, Immunologic | 7 | 2015 | 61 | 1.360 |
Why?
|
| Bacterial Proteins | 7 | 2009 | 93 | 1.040 |
Why?
|
| Receptors, Cell Surface | 6 | 2005 | 78 | 0.970 |
Why?
|
| Membrane Glycoproteins | 7 | 2011 | 111 | 0.960 |
Why?
|
| Interleukin-1 | 17 | 2000 | 48 | 0.800 |
Why?
|
| Toll-Like Receptor 5 | 7 | 2009 | 11 | 0.650 |
Why?
|
| Mice | 30 | 2011 | 2571 | 0.610 |
Why?
|
| Pseudomonas Vaccines | 2 | 2009 | 3 | 0.600 |
Why?
|
| Protein Kinases | 5 | 2002 | 34 | 0.590 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2009 | 40 | 0.580 |
Why?
|
| Monocytes | 7 | 2002 | 141 | 0.550 |
Why?
|
| Plague Vaccine | 2 | 2008 | 3 | 0.530 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2008 | 215 | 0.530 |
Why?
|
| Animals | 36 | 2015 | 8199 | 0.530 |
Why?
|
| Mice, Inbred BALB C | 11 | 2011 | 196 | 0.520 |
Why?
|
| Antibodies, Bacterial | 4 | 2009 | 34 | 0.510 |
Why?
|
| Immunity, Innate | 3 | 2008 | 82 | 0.480 |
Why?
|
| Vaccinia virus | 3 | 2011 | 19 | 0.480 |
Why?
|
| Macrophages | 12 | 2005 | 207 | 0.470 |
Why?
|
| Salmonella | 3 | 2000 | 6 | 0.440 |
Why?
|
| Lung | 5 | 2009 | 263 | 0.430 |
Why?
|
| Vaccinia | 2 | 2011 | 9 | 0.410 |
Why?
|
| Pseudomonas Infections | 2 | 2009 | 17 | 0.380 |
Why?
|
| Gram-Negative Bacteria | 2 | 2004 | 8 | 0.370 |
Why?
|
| Cell Line | 15 | 2010 | 454 | 0.370 |
Why?
|
| Lipoproteins | 2 | 2009 | 95 | 0.360 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 47 | 0.340 |
Why?
|
| Flagella | 2 | 2002 | 3 | 0.340 |
Why?
|
| Cytokines | 2 | 2004 | 237 | 0.340 |
Why?
|
| Smallpox Vaccine | 1 | 2010 | 6 | 0.320 |
Why?
|
| Complement System Proteins | 1 | 2010 | 7 | 0.320 |
Why?
|
| Yersinia pestis | 2 | 2008 | 3 | 0.310 |
Why?
|
| Signal Transduction | 5 | 2003 | 727 | 0.300 |
Why?
|
| Epitopes | 2 | 2009 | 26 | 0.300 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 120 | 0.290 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2008 | 7 | 0.290 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 15 | 0.290 |
Why?
|
| Recombinant Proteins | 7 | 2008 | 264 | 0.280 |
Why?
|
| T-Lymphocytes | 7 | 2015 | 140 | 0.280 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 6 | 0.280 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 174 | 0.250 |
Why?
|
| Toll-Like Receptors | 5 | 2005 | 30 | 0.240 |
Why?
|
| Immunoglobulin G | 5 | 2015 | 129 | 0.240 |
Why?
|
| Plague | 1 | 2006 | 1 | 0.240 |
Why?
|
| Immunity, Active | 1 | 2005 | 2 | 0.220 |
Why?
|
| Gangliosides | 1 | 2005 | 7 | 0.220 |
Why?
|
| Dendritic Cells | 3 | 2010 | 61 | 0.220 |
Why?
|
| DNA-Binding Proteins | 4 | 2003 | 149 | 0.220 |
Why?
|
| Protein Precursors | 3 | 1991 | 24 | 0.220 |
Why?
|
| Mice, Inbred C3H | 8 | 2005 | 36 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Enterobacteriaceae | 1 | 2003 | 12 | 0.200 |
Why?
|
| Lipopolysaccharides | 7 | 2002 | 121 | 0.190 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2001 | 6 | 0.190 |
Why?
|
| Nitric Oxide | 1 | 2003 | 121 | 0.190 |
Why?
|
| Humans | 20 | 2016 | 32282 | 0.180 |
Why?
|
| Interleukin-2 | 7 | 2009 | 38 | 0.180 |
Why?
|
| Transfection | 5 | 2003 | 204 | 0.180 |
Why?
|
| Aging | 1 | 2008 | 942 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2010 | 839 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Transcription Factors | 3 | 1991 | 183 | 0.170 |
Why?
|
| Viral Envelope Proteins | 2 | 2011 | 11 | 0.170 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 6 | 0.160 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 19 | 0.160 |
Why?
|
| Female | 14 | 2016 | 19945 | 0.160 |
Why?
|
| Viral Matrix Proteins | 2 | 2010 | 12 | 0.160 |
Why?
|
| Vesicular stomatitis Indiana virus | 2 | 2010 | 16 | 0.160 |
Why?
|
| Protein Binding | 4 | 2005 | 244 | 0.160 |
Why?
|
| Peptides | 1 | 2000 | 127 | 0.150 |
Why?
|
| Immunization | 3 | 2010 | 38 | 0.150 |
Why?
|
| Complement C3 | 2 | 2009 | 11 | 0.150 |
Why?
|
| Salmonella enteritidis | 3 | 2004 | 4 | 0.150 |
Why?
|
| COS Cells | 3 | 2003 | 33 | 0.140 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 1991 | 17 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 290 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2006 | 792 | 0.120 |
Why?
|
| Macaca fascicularis | 2 | 2008 | 542 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 23 | 0.110 |
Why?
|
| Viral Vaccines | 2 | 2011 | 14 | 0.110 |
Why?
|
| Lymphokines | 5 | 1983 | 16 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 82 | 0.100 |
Why?
|
| Plasmids | 2 | 2005 | 50 | 0.100 |
Why?
|
| Vaccination | 1 | 2015 | 156 | 0.100 |
Why?
|
| Time Factors | 4 | 2008 | 2205 | 0.100 |
Why?
|
| Vaccines, Synthetic | 2 | 2010 | 14 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 1991 | 140 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2003 | 46 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2009 | 58 | 0.090 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2002 | 16 | 0.090 |
Why?
|
| Paramyxovirinae | 1 | 2011 | 3 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1991 | 9 | 0.090 |
Why?
|
| Temperature | 2 | 2008 | 58 | 0.090 |
Why?
|
| Calpain | 1 | 1991 | 14 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 40 | 0.090 |
Why?
|
| Endopeptidases | 1 | 1991 | 29 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1991 | 83 | 0.080 |
Why?
|
| Vesicular Stomatitis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Genetic Engineering | 1 | 2010 | 22 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2002 | 84 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2002 | 90 | 0.080 |
Why?
|
| Antibody Specificity | 2 | 2009 | 17 | 0.080 |
Why?
|
| Injections, Intramuscular | 1 | 2010 | 53 | 0.080 |
Why?
|
| Hela Cells | 1 | 2010 | 72 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1990 | 81 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 15 | 0.080 |
Why?
|
| Receptors, Immunologic | 2 | 1987 | 24 | 0.080 |
Why?
|
| Macrophage Activation | 2 | 2001 | 13 | 0.080 |
Why?
|
| Complement Activation | 1 | 2009 | 8 | 0.080 |
Why?
|
| Immunity, Humoral | 1 | 2009 | 14 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2009 | 6 | 0.080 |
Why?
|
| Chickens | 1 | 2009 | 36 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 1990 | 145 | 0.070 |
Why?
|
| Microbial Viability | 1 | 2009 | 5 | 0.070 |
Why?
|
| Mutation | 2 | 2010 | 497 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 18 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 1989 | 43 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2009 | 68 | 0.070 |
Why?
|
| Drug Stability | 1 | 2008 | 11 | 0.070 |
Why?
|
| Drug Storage | 1 | 2008 | 5 | 0.070 |
Why?
|
| Virulence Factors | 1 | 2008 | 11 | 0.070 |
Why?
|
| Immunization, Secondary | 1 | 2008 | 12 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 1999 | 50 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 257 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 359 | 0.070 |
Why?
|
| Chromatography, Gel | 5 | 1997 | 16 | 0.070 |
Why?
|
| Administration, Intranasal | 1 | 2008 | 35 | 0.070 |
Why?
|
| Antibodies, Viral | 3 | 2015 | 65 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 59 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2008 | 224 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2008 | 477 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1986 | 13 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2008 | 200 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 1989 | 243 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2002 | 20 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2002 | 299 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 603 | 0.060 |
Why?
|
| Molecular Weight | 5 | 1997 | 55 | 0.060 |
Why?
|
| Thymus Gland | 1 | 1986 | 15 | 0.060 |
Why?
|
| Fibroblasts | 1 | 1987 | 119 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2002 | 250 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 164 | 0.060 |
Why?
|
| Trypsin | 2 | 2000 | 10 | 0.060 |
Why?
|
| Monokines | 2 | 2004 | 2 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1985 | 37 | 0.060 |
Why?
|
| Cell Communication | 1 | 1985 | 37 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2003 | 499 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2011 | 99 | 0.060 |
Why?
|
| Chemokine CCL4 | 1 | 2004 | 5 | 0.050 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2004 | 4 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2004 | 23 | 0.050 |
Why?
|
| Chemokine CXCL2 | 1 | 2004 | 10 | 0.050 |
Why?
|
| Neutrophils | 1 | 2004 | 120 | 0.050 |
Why?
|
| Kinetics | 2 | 2001 | 250 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 854 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 18 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 13 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 20 | 0.050 |
Why?
|
| Centrifugation | 1 | 2003 | 4 | 0.050 |
Why?
|
| Interferon-beta | 1 | 2003 | 19 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 46 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 41 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 43 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2003 | 59 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 112 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 144 | 0.050 |
Why?
|
| Male | 6 | 2016 | 19441 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 203 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 7 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2002 | 41 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1300 | 0.050 |
Why?
|
| Cell Separation | 1 | 2002 | 89 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2002 | 184 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2001 | 138 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2000 | 2 | 0.040 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2000 | 3 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2000 | 6 | 0.040 |
Why?
|
| Leupeptins | 1 | 2000 | 7 | 0.040 |
Why?
|
| Acrylates | 1 | 2000 | 2 | 0.040 |
Why?
|
| Half-Life | 1 | 2000 | 24 | 0.040 |
Why?
|
| Lactones | 1 | 2000 | 13 | 0.040 |
Why?
|
| Leucine | 1 | 2000 | 23 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 23 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 1991 | 55 | 0.040 |
Why?
|
| Polymyxin B | 1 | 1999 | 1 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 1991 | 478 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 146 | 0.040 |
Why?
|
| Leukemia P388 | 3 | 1989 | 5 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 16 | 0.030 |
Why?
|
| HIV | 1 | 1997 | 26 | 0.030 |
Why?
|
| Virus Replication | 1 | 1997 | 42 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 1989 | 111 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 79 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2015 | 40 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 136 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 1984 | 8 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1986 | 245 | 0.030 |
Why?
|
| Adult | 1 | 2016 | 9259 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1986 | 7 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 10263 | 0.020 |
Why?
|
| Cycloheximide | 2 | 1985 | 10 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1985 | 42 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 11851 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2011 | 12 | 0.020 |
Why?
|
| Ethers, Cyclic | 1 | 1991 | 1 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1991 | 3 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 1991 | 6 | 0.020 |
Why?
|
| Thymoma | 1 | 1991 | 7 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2011 | 21 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1991 | 7 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 23 | 0.020 |
Why?
|
| Ionomycin | 1 | 1991 | 5 | 0.020 |
Why?
|
| Calcimycin | 1 | 1991 | 8 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1991 | 41 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1991 | 66 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1991 | 63 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1083 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 150 | 0.020 |
Why?
|
| Salmonella enterica | 1 | 2010 | 6 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1990 | 19 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1990 | 21 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2010 | 12 | 0.020 |
Why?
|
| Rabbits | 3 | 1985 | 219 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 717 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 1989 | 1 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2010 | 108 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1989 | 8 | 0.020 |
Why?
|
| Cytosol | 1 | 1989 | 23 | 0.020 |
Why?
|
| Calcium | 1 | 1991 | 339 | 0.020 |
Why?
|
| Biological Transport | 1 | 1989 | 75 | 0.020 |
Why?
|
| Catalysis | 1 | 1989 | 71 | 0.020 |
Why?
|
| Fixatives | 1 | 1989 | 4 | 0.020 |
Why?
|
| Formaldehyde | 1 | 1989 | 15 | 0.020 |
Why?
|
| Antibodies | 1 | 1989 | 56 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2008 | 23 | 0.020 |
Why?
|
| Polymers | 1 | 1989 | 66 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2008 | 29 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 1985 | 43 | 0.020 |
Why?
|
| Sarcoma, Experimental | 1 | 1987 | 7 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1987 | 4 | 0.020 |
Why?
|
| Endocytosis | 1 | 1987 | 9 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1987 | 43 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1987 | 109 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 55 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1986 | 44 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 1984 | 94 | 0.020 |
Why?
|
| H-2 Antigens | 1 | 1985 | 8 | 0.010 |
Why?
|
| Poly A | 1 | 1985 | 1 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1985 | 2 | 0.010 |
Why?
|
| Mice, Inbred DBA | 3 | 1980 | 42 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1984 | 31 | 0.010 |
Why?
|
| RNA | 1 | 1985 | 94 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1986 | 461 | 0.010 |
Why?
|
| Proteins | 2 | 1983 | 149 | 0.010 |
Why?
|
| Phenotype | 1 | 1985 | 622 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1983 | 8 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 2 | 1980 | 4 | 0.010 |
Why?
|
| Pyrogens | 1 | 1981 | 1 | 0.010 |
Why?
|
| Serum Amyloid A Protein | 1 | 1981 | 5 | 0.010 |
Why?
|
| Amyloid | 1 | 1981 | 16 | 0.010 |
Why?
|
| Antigens | 1 | 1980 | 34 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1980 | 17 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1979 | 17 | 0.010 |
Why?
|
| Biological Products | 1 | 1980 | 79 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1978 | 16 | 0.010 |
Why?
|
| Growth Substances | 2 | 1984 | 9 | 0.010 |
Why?
|
| Mice, Inbred AKR | 2 | 1984 | 6 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1987 | 73 | 0.000 |
Why?
|
| Body Weight | 1 | 1987 | 323 | 0.000 |
Why?
|
| Conalbumin | 1 | 1984 | 1 | 0.000 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1984 | 7 | 0.000 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1983 | 1 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1983 | 5 | 0.000 |
Why?
|
| Antibody-Producing Cells | 1 | 1983 | 4 | 0.000 |
Why?
|
| Interleukin-5 | 1 | 1983 | 7 | 0.000 |
Why?
|
| Antigens, Ly | 1 | 1983 | 7 | 0.000 |
Why?
|
| Interleukin-4 | 1 | 1983 | 22 | 0.000 |
Why?
|
| Clone Cells | 1 | 1983 | 35 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1983 | 19 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1983 | 47 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1980 | 3 | 0.000 |
Why?
|
| Culture Media | 1 | 1980 | 48 | 0.000 |
Why?
|
| Cell Division | 1 | 1980 | 92 | 0.000 |
Why?
|
| Cell Adhesion | 1 | 1980 | 100 | 0.000 |
Why?
|
| Isoantigens | 1 | 1980 | 3 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1980 | 19 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1980 | 42 | 0.000 |
Why?
|